Tadalafil Tamsulosin Benign Prostate Hyperplasia Meta-Analysis

Imidafenacin Overactive Bladder Benign Prostatic Hyperplasia Meta-Analysis

Aged Aged 80 and over Humans Male Middle Aged Outcome Assessment Health Care Plant Extracts/administration & dosage Prostatic Hyperplasia/*drug therapy Serenoa Tamsulosin/administration & dosage Urological Agents/administration & dosage *Serenoa repens *benign prostatic hyperplasia *meta-analysis *randomized controlled trials *tamsulosin conflicts of interest with respect to the research authorship and/or publication of this article.

Aged Drug Therapy Combination Erectile Dysfunction/*drug therapy Humans Male Middle Aged Phosphodiesterase Inhibitors Prostatic Hyperplasia/*drug therapy Tadalafil Tamsulosin Treatment Outcome Vasodilator Agents *benign prostatic hyperplasia *erectile dysfunction *meta-analysis *tadalafil *tamsulosin conflicts of interest with respect to the research authorship and/or publication of this article.

5-alpha Reductase Inhibitors/*administration & dosage Adrenergic alpha-1 Receptor Antagonists/*administration & dosage Drug Therapy Combination Dutasteride/*administration & dosage Erectile Dysfunction/chemically induced/diagnosis Humans Male Prostatic Hyperplasia/diagnosis/*drug therapy/epidemiology Randomized Controlled Trials as Topic/methods Tamsulosin/*administration & dosage Treatment Outcome Benign prostatic hyperplasia Dutasteride Meta-analysis Randomized controlled trials Tamsulosin published studies thus no ethical approval and patient consent are required. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Systematic Review Meta-analysis Holmium Laser Enucleation of Prostate Transurethral Resection of Prostate Benign Prostatic Hyperplasia

Oral antithrombotic drugs benign prostate hyperplasia

*Bipolar Disorder China Humans Male Prostatectomy *Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Treatment Outcome Benign prostatic hyperplasia High-risk and senior patients Meta-analysis Systematic review Transurethral bipolar plasmakinetic prostatectomy

Enucleation Resection of prostate Benign prostatic hyperplasia Meta-analysis

Phosphodiesterase type 5 inhibitor Lower urinary tract symptoms Benign prostatic hyperplasia Meta-analysis

Blood Transfusion Clinical Trials as Topic Humans Length of Stay Male Minimally Invasive Surgical Procedures Operative Time Prostate Prostatectomy Prostatic Hyperplasia Quality of Life Treatment Outcome Urinary Retention *benign prostatic hyperplasia *laparoscopic *minimally invasive simple prostatectomy *open simple prostatectomy *robotic

Humans Length of Stay Male Perioperative Period Prostate/pathology Prostatic Hyperplasia/epidemiology/pathology Randomized Controlled Trials as Topic Saline Solution Transurethral Resection of Prostate/*adverse effects/*economics/standards Treatment Outcome United Kingdom/epidemiology Urethral Stricture/complications Urologic Surgical Procedures *Bph *Benign prostate enlargement *Benign prostate hyperplasia *Cost minimisation analysis *Meta-analysis *TUR syndrome *Turp *TURis *Transurethral resection in saline *Transurethral resection of the prostate

Finasteride benign prostatic hyperplasia meta-analysis

Humans Laser Coagulation Laser Therapy Lasers Solid-State Male Non-Randomized Controlled Trials as Topic/statistics & numerical data Prostatic Hyperplasia/complications Quality of Life Randomized Controlled Trials as Topic/statistics & numerical data *Thulium Transurethral Resection of Prostate Treatment Outcome Ureteral Obstruction/etiology 2-micron Benign prostatic obstruction Plasmakinetic resection of prostate Safety and efficacy Thulium laser VapoResection of the prostate Thulium laser Transurethral resection of the prostate

Acupuncture benign prostatic hyperplasia meta-analysis

Bph Srd5a2 polymorphism risk susceptibility

Finasteride Dutasteride Benign Prostatic Hyperplasia Meta-Analysis

Prostatic Artery Embolization Benign Prostatic Hyperplasia Meta-Analysis

*Alleles Ethnicity/genetics *Genetic Association Studies *Genetic Predisposition to Disease Genotype Humans Male Odds Ratio *Polymorphism Single Nucleotide Prostate-Specific Antigen/*genetics Prostatic Hyperplasia/*genetics Publication Bias Risk Factors Bph Psa meta-analysis polymorphism

5-alpha Reductase Inhibitors/pharmacology Blood Loss Surgical/*prevention & control Blood Transfusion Dutasteride/*pharmacology Hemoglobins/analysis Humans Male Microcirculation Prospective Studies Prostate Prostatic Hyperplasia Randomized Controlled Trials as Topic Retrospective Studies *Transurethral Resection of Prostate Treatment Outcome Vascular Endothelial Growth Factor A/metabolism Benign prostatic hyperplasia Dutasteride Intraoperative blood loss Meta-analysis Transurethral resection of the prostate